**Core Concept**
The 5HT3 receptor is a subtype of serotonin receptor, specifically a ligand-gated ion channel that plays a crucial role in the transmission of nerve impulses in the central and peripheral nervous system. It is involved in various physiological processes, including nausea, vomiting, and pain regulation.

**Why the Correct Answer is Right**
Ondansetron is a selective serotonin 5HT3 receptor antagonist, which means it binds to the 5HT3 receptor and blocks its action without affecting other serotonin receptor subtypes. By inhibiting the 5HT3 receptor, ondansetron reduces the release of neurotransmitters that stimulate the vomiting center in the brain, making it an effective antiemetic medication. This mechanism of action is distinct from other classes of antiemetic agents that target dopamine or histamine receptors.

**Why Each Wrong Option is Incorrect**
**Option A:** Metoclopramide is a dopamine antagonist that also has some effect on 5HT4 receptors, but it is not a selective 5HT3 receptor antagonist.
**Option B:** Chlorpromazine is a typical antipsychotic that has a broad range of pharmacological effects, including blockade of dopamine and alpha-adrenergic receptors, but it is not a selective 5HT3 receptor antagonist.
**Option C:** Domperidone is a dopamine antagonist that primarily affects the gastrointestinal system, but it is not a selective 5HT3 receptor antagonist.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that 5HT3 receptor antagonists, like ondansetron, are effective in preventing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV).

**Correct Answer:** C. Ondansetron.